167 related articles for article (PubMed ID: 1911888)
1. The neuromelanin of the human substantia nigra.
Carstam R; Brinck C; Hindemith-Augustsson A; Rorsman H; Rosengren E
Biochim Biophys Acta; 1991 Sep; 1097(2):152-60. PubMed ID: 1911888
[TBL] [Abstract][Full Text] [Related]
2. Cysteinyldopamine is not incorporated into neuromelanin.
Wakamatsu K; Ito S; Nagatsu T
Neurosci Lett; 1991 Sep; 131(1):57-60. PubMed ID: 1791980
[TBL] [Abstract][Full Text] [Related]
3. The structure of neuromelanin as studied by chemical degradative methods.
Wakamatsu K; Fujikawa K; Zucca FA; Zecca L; Ito S
J Neurochem; 2003 Aug; 86(4):1015-23. PubMed ID: 12887698
[TBL] [Abstract][Full Text] [Related]
4. Neuromelanin of the human substantia nigra: a mixed-type melanin.
Odh G; Carstam R; Paulson J; Wittbjer A; Rosengren E; Rorsman H
J Neurochem; 1994 May; 62(5):2030-6. PubMed ID: 8158151
[TBL] [Abstract][Full Text] [Related]
5. Melanins in IGR 1 melanoma cells.
Odh G; Hindemith A; Carstam R; Paulson J; Rosengren E; Rorsman H
Pigment Cell Res; 1994 Dec; 7(6):419-27. PubMed ID: 7761350
[TBL] [Abstract][Full Text] [Related]
6. GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.
Dzierzega-Lecznar A; Kurkiewicz S; Stepien K; Chodurek E; Wilczok T; Arzberger T; Riederer P; Gerlach M
J Am Soc Mass Spectrom; 2004 Jun; 15(6):920-6. PubMed ID: 15144983
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of 4-amino-3-hydroxyphenylalanine as a specific marker of pheomelanin.
Wakamatsu K; Ito S; Rees JL
Pigment Cell Res; 2002 Jun; 15(3):225-32. PubMed ID: 12028587
[TBL] [Abstract][Full Text] [Related]
8. Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins.
Double KL; Zecca L; Costi P; Mauer M; Griesinger C; Ito S; Ben-Shachar D; Bringmann G; Fariello RG; Riederer P; Gerlach M
J Neurochem; 2000 Dec; 75(6):2583-9. PubMed ID: 11080212
[TBL] [Abstract][Full Text] [Related]
9. Structural investigations of neuromelanin by pyrolysis-gas chromatography/mass spectrometry.
Dzierzega-Lecznar A; Kurkiewicz S; Stepien K; Chodurek E; Riederer P; Gerlach M
J Neural Transm (Vienna); 2006 Jun; 113(6):729-34. PubMed ID: 16755376
[TBL] [Abstract][Full Text] [Related]
10. Chemical degradation of melanins: application to identification of dopamine-melanin.
Ito S; Wakamatsu K
Pigment Cell Res; 1998 Apr; 11(2):120-6. PubMed ID: 9585251
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of alkaline hydrogen peroxide oxidation to analyze eumelanin and pheomelanin in various tissue samples: application to chemical analysis of human hair melanins.
Ito S; Nakanishi Y; Valenzuela RK; Brilliant MH; Kolbe L; Wakamatsu K
Pigment Cell Melanoma Res; 2011 Aug; 24(4):605-13. PubMed ID: 21535429
[TBL] [Abstract][Full Text] [Related]
12. Dolichol is the major lipid component of human substantia nigra neuromelanin.
Fedorow H; Pickford R; Hook JM; Double KL; Halliday GM; Gerlach M; Riederer P; Garner B
J Neurochem; 2005 Feb; 92(4):990-5. PubMed ID: 15686500
[TBL] [Abstract][Full Text] [Related]
13. Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography.
Ito S; Fujita K
Anal Biochem; 1985 Feb; 144(2):527-36. PubMed ID: 3993914
[TBL] [Abstract][Full Text] [Related]
14. Melanins and lens pigments: a comparative study.
Cuevas AA; García-Castiñeiras S
P R Health Sci J; 1993 Jun; 12(2):129-35. PubMed ID: 8210284
[TBL] [Abstract][Full Text] [Related]
15. Photodegradation of Eumelanin and Pheomelanin and Its Pathophysiological Implications.
Ito S; Wakamatsu K; Sarna T
Photochem Photobiol; 2018 May; 94(3):409-420. PubMed ID: 28873228
[TBL] [Abstract][Full Text] [Related]
16. Neuromelanin of the human substantia nigra: an update.
Zucca FA; Basso E; Cupaioli FA; Ferrari E; Sulzer D; Casella L; Zecca L
Neurotox Res; 2014 Jan; 25(1):13-23. PubMed ID: 24155156
[TBL] [Abstract][Full Text] [Related]
17. UVA-induced oxidative degradation of melanins: fission of indole moiety in eumelanin and conversion to benzothiazole moiety in pheomelanin.
Wakamatsu K; Nakanishi Y; Miyazaki N; Kolbe L; Ito S
Pigment Cell Melanoma Res; 2012 Jul; 25(4):434-45. PubMed ID: 22551214
[TBL] [Abstract][Full Text] [Related]
18. Biosynthetic pathway to neuromelanin and its aging process.
Wakamatsu K; Murase T; Zucca FA; Zecca L; Ito S
Pigment Cell Melanoma Res; 2012 Nov; 25(6):792-803. PubMed ID: 22938712
[TBL] [Abstract][Full Text] [Related]
19. DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease.
Cai W; Wakamatsu K; Zucca FA; Wang Q; Yang K; Mohamadzadehonarvar N; Srivastava P; Tanaka H; Holly G; Casella L; Ito S; Zecca L; Chen X
Prog Neurobiol; 2023 Apr; 223():102414. PubMed ID: 36746222
[TBL] [Abstract][Full Text] [Related]
20. HPLC analysis of pheomelanin degradation products in human urine.
Takasaki A; Nezirević D; Arstrand K; Wakamatsu K; Ito S; Kågedal B
Pigment Cell Res; 2003 Oct; 16(5):480-6. PubMed ID: 12950724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
